Two-year outcomes after mitraclip treatment of functional mitral regurgitation in ischemic and non-ischemic dilated cardiomyopathy.
Event: ESC Congress 2017
Topic: CHF - Non pharmacological treatment
Session: Devices and multidisciplinary interventions in heart failure
Observed versus predicted mortality after mitraclip treatment in patients with symptomatic heart failure and significant functional mitral regurgitation
Event: ESC Congress 2017
Topic: Prognosis
Session: Devices and multidisciplinary interventions in heart failure
ESC 365 is supported by
